NOF Corporation (TYO:4403)

Japan flag Japan · Delayed Price · Currency is JPY
2,879.50
+44.50 (1.57%)
Aug 8, 2025, 2:45 PM JST
1.57%
Market Cap652.30B
Revenue (ttm)239.26B
Net Income (ttm)34.06B
Shares Out230.09M
EPS (ttm)144.50
PE Ratio19.62
Forward PE17.09
Dividend48.00 (1.64%)
Ex-Dividend DateSep 29, 2025
Volume1,273,500
Average Volume857,620
Open2,823.50
Previous Close2,835.00
Day's Range2,799.50 - 2,899.50
52-Week Range1,739.00 - 3,086.00
Beta0.67
RSI41.26
Earnings DateAug 6, 2025

About Sage Therapeutics

NOF Corporation manufactures chemicals in Japan. It operates through Functional Chemicals, Pharmaceuticals, Medicals and Health, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, petrochemical products, and electronic materials, as well as special anti-corrosion prevention agents. The Pharmaceuticals, Medicals and Health segment provides edible oils, functional food materi... [Read more]

Sector Materials
Founded 1937
Employees 3,997
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4403
Full Company Profile

Financial Performance

In 2024, NOF Corporation's revenue was 238.31 billion, an increase of 7.23% compared to the previous year's 222.25 billion. Earnings were 36.50 billion, an increase of 7.38%.

Financial numbers in IDR Financial Statements

News

There is no news available yet.